GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an upbeat assessment of the firm's prospects at an investor meeting last week would deflect criticism of her leadership from ...

Trump's call with Xi, which both leaders framed as positive, came after weeks of Trump publicly pushing for the talk. US-China tensions have risen in the aftermath of the countries' trade truce ...

In a rare move, the FDA has publicly accused US biotech CytoDyn of misrepresenting clinical trial results for leronlimab, an antibody being developed for COVID-19. It's not uncommon for drug ...